• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The elucidation of the radiation resistance in melanoma : the relationship between melanogenesis and Elkind recovery

Research Project

Project/Area Number 14570889
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Radiation science
Research InstitutionKawasaki Medical School

Principal Investigator

HIRATSUKA Junichi  Kawasaki Medical School, medical dep., assistant professor, 医学部, 助教授 (30192298)

Co-Investigator(Kenkyū-buntansha) KONDO Hirofumi  Bio-Research Inc., Active director/senior researcher, 代表取締役/主任研究員(研究職)
OTUSKI Takemi  Kawasaki Medical School, medical dep., professor, 医学部, 教授 (40160551)
近藤 浩文  (株)バイオリサーチ, 代表取締役・主任研究員(研究職)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥1,400,000 (Direct Cost: ¥1,400,000)
Keywordsmalignant melanoma / radiation resistance / Elkind recovery / melanogenesis / tyrosinase related protein-2 / cell cycle / homologous recombinational repair / RAD 51 family
Research Abstract

There are several reports that TRP-2 plays a critical role in the resistance against the DNA damaging agents such as CDDP and the ultraviolet irradiation. In our fundamental experiment, it has become clear that there is a close correlation between the melanin producing activity and the X-ray radiation resistance of the melanoma cells. We reviewed the relation between the melanogenesis and the resistance to X-ray irradiation using human melanoma cell lines.
IDT-10 cells which were transfected the human TRP-2 expression plasmid into Ihara cells, highly pigmented human melanoma cell line, were used in this study, there was not much difference in cell growth between Ihara cells and IDT-10 cells. The expression levels of TRP-2 protein and the amounts of total melanin in IDT-10 cells were 2.8 and 1.5 times as high as those in Ihara cells, respectively.
In the clonogenic assay, the enhancement of "Elkind recovery" was observed in IDT-10 cells, and the survival rates of IDT-10 cells were higher than those of Ihara cells after irradiation with 4 MV X-rays. Elkind recovery is the result of the repair of sublethal damage that is due to DNA double-strand breaks(DSBs) repair mediated by homologous recombination in late S-G2 phase. Ihara and IDT-10 cells were tested with flow cytometry, and significant accumulation of cells in the S-G2 phase was observed in IDT-10 cells until 64 h after 8Gy irradiation. In addition, IDT-10 cells showed a significantly higher level of ERK phosphorylation relative to Ihara cells after irradiation by Western analysis.
These results suggested that radiation resistance associated with TRP-2 expression in melanoma was due to cell cycle regulation by active-ERK and due to increase DNA DSBs repair capacity in late S-G2 phase.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Iwakura M, et al.: "Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain"Pigment Cell Res. 15. 67-75 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fukuda H, et al.: "Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor"Australas Phys Eng Sci Med. 26(3). 97-103 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morita N, et al.: "Enhanced Melanogenesis Induced by Intra-Tumor Injection of Tyrosinase Gene and Killing Effect of BNCT for Amelanotic Melanoma"KURRI Prog. Rep. 2002. 151 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morita N, et al.: "Enhanced Killing Effect of BNCT for D178 Amelanotic Melanoma by In Vivo Direct Gene Transfer"KURRI Prog. Rep. 2003. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Iwakura M, et al.: "Effect of boron neutron capture therapy for melanotic and amelanotic melanoma transplanted into mouse brain"Pigment Cell Res.. 15(1). 67-74 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Fukuda H, et al.: "Boron neutron capture therapy(BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor"Australas Phys Eng Sci Med.. (26)3. 97-103 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morita N, et al.: "Enhanced Melanogenesis Induced by Intra-Tumor Injection of Tyrosinase Gene and Killing Effect of BNCT for Amelanotic Melanoma"KURRI PROG.RE. 2002. 151 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morita N, et al.: "Enhanced Killing Effect of BNCT for D178 Amelanotic Melanoma by In Vivo Direct Gene Transfer"KURRI PROG.RE. (In Press). (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi